GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » Total Stockholders Equity

Raily Aesthetic Medicine International Holdings (HKSE:02135) Total Stockholders Equity : HK$182.0 Mil (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings Total Stockholders Equity?

Raily Aesthetic Medicine International Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2023 was HK$182.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Raily Aesthetic Medicine International Holdings's Book Value per Share for the quarter that ended in Jun. 2023 was HK$0.38. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Raily Aesthetic Medicine International Holdings's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.31.


Raily Aesthetic Medicine International Holdings Total Stockholders Equity Historical Data

The historical data trend for Raily Aesthetic Medicine International Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raily Aesthetic Medicine International Holdings Total Stockholders Equity Chart

Raily Aesthetic Medicine International Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial 103.55 220.34 218.23 185.46 151.07

Raily Aesthetic Medicine International Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 218.23 212.98 185.46 182.00 151.07

Raily Aesthetic Medicine International Holdings  (HKSE:02135) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Raily Aesthetic Medicine International Holdings's Book Value per Share for the quarter that ended in Jun. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Raily Aesthetic Medicine International Holdings's Debt-to-Equity for the quarter that ended in Jun. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raily Aesthetic Medicine International Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Traded in Other Exchanges
N/A
Address
No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN
Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.
Executives
Fu Haishu 2201 Interest of corporation controlled by you
Jin Chunmiao 2202 Interest of your spouse
Ruide Consultation Limited 2101 Beneficial owner
Youxin Management Co., Limited 2101 Beneficial owner
Beauty Milkway (hk) Limited
China Orient Asset Management (international) Holding Limited
China Orient Asset Management Co., Ltd.
Dong Yin Development (holdings) Limited
Wise Leader Assets Ltd.
Shang Hai Dong Hua Jian Kang Guan Li He Huo Qi Ye You Xian He Huo
Dong Fang Zi Chan Guan Li Zhong Guo Kong Gu You Xian Gong Si
Shen Zhen Dong Fang Chuang Ye Tou Zi You Xian Gong Si
Shen Zhen Qian Hai Cai Fu Dong Fang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Fa Zhan Ji Jin You Xian He Huo
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Tou Zi Guan Li You Xian Gong Si

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines